GTR 101830481
Bids Are Invited For Price Registration For Future Drug Acquisition, To Meet The Demands Of The Antonio Martins Da Costa Municipal Hospital And The Citizen Pharmacy (Work Plans No. 202400010005236, No. 202400010005282, No. 202400010005284, No. 2025005012929, No. 202500005012928, No. 202500042006680), Under The Supervision Of The Municipal Health Fund Of Quirinópolis-Go, According To Specifications And Quantities Established In Dfd, Etp And Term Of Reference, Annexes In This Process.
ICB — International Competitive Bid
Closed
South America
Tender Information
GTR Reference
101830481
Tendering Authority
Subscribe to view
Tender No
125/2025
Financer Name
Self-Funded
Work Title
Bids Are Invited For Price Registration For Future Drug Acquisition, To Meet The Demands Of The Antonio Martins Da Costa Municipal Hospital And The Citizen Pharmacy (Work Plans No. 202400010005236, No. 202400010005282, No. 202400010005284, No. 2025005012929, No. 202500005012928, No. 202500042006680), Under The Supervision Of The Municipal Health Fund Of Quirinópolis-Go, According To Specifications And Quantities Established In Dfd, Etp And Term Of Reference, Annexes In This Process.
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
25-09-2025
Closed
Work Detail
Acebrophylline, Dosage/Concentration: 10 Mg/Ml, Pharmaceutical Form: Syrup 120Ml (Br0448839), Dosage/Concentration: 5 Mg/Ml, Pharmaceutical Form: Syrup 120Ml (Br0448838), Tranexamic Acid, Dosage/Concentration: 50 Mg/Ml, Ampoule Injectable Solution 5Ml (Br0327566), Distilled Water, Physical Aspect: Bidestilated, Sterile, Apirogenic, 10Ml Ampoule (Br0315056), Acetylsalicylic Acid, Dosage/Concentration: 100 Mg (Br0267502), 11/09/2025, Ascorbic Acid, Dosage/Concentration: 100 Mg/Ml, Type Ampoule 5Ml (Br0271687), Épsilon-Amaminocaproic Acid, Dosage/Concentration: 500Mg, Human Albumin, Use: Injectable, Dosage/Concentration: 20% Vial 50Ml (Br0268376), Alteplase, Dosage/Concentration: 50 Mg, Liophile Powder P/Injectable + Diluent (Br0436418), Ambroxol, Composition: Salt Hydrochloride, Dosage/Concentration: 6 Mg/Ml, Pharmaceutical Form: Syrup 120Ml (Br0446263), Amoxicillin, Dosage/Concentration: 500Mg (Br0271089), Dosage/Concentration: 875Mg + 125Mg, Active Ingredient (Br0353333), Amphotericin B, Dosage/Concentration: 100 Mg, Pharmaceutical Form: Liophile Powder For Injectable, Additional Characteristics: Liposomal (Br0276823), Dosage/Concentration: 20 Mg/Ml, Pharmaceutical Form: Oral Suspension - Drops 30Ml (Br0476830) Atomoxetine Hydrochloride, Oral Use, Dosage/Concentration: 10Mg, Axethylcefuroxima, Dosage/Concentration: 500Mg, Azithromycin, Dosage/Concentration: 500 Mg (Br0267140), Beclomethasone Dipropionate Of Oral Aerosol, Dosage/Concentration: 50Mcg, Accompanied By Inhaler (Device For Unaltation L -Shaped Oral), 200 Doses, Benzilpenyicillin, Dosage/Concentration: 1.200.000Ui, Presentation: Benzatin (Br0270612), Dosage/Concentration: 600.000Ui, Presentation: Benzatin, Bisoprolol Fumarate, Dosage/Concentration: 1, 25 Mg (Br0362719), Dosage/Concentration: 2, 5 Mg (Br0362720), Bromopride, Presentation: Injectable Ampoule 2Ml (Br0269958), Bupropion Hydrochloride, Dosage/Concentration: 150 Mg, Additional Characteristics: Prolonged Release (Br0460986), Captopril, Dosage/Concentration: 25 Mg (Br0267613) Dosage/Concentration: 500 Mg (Br0267625), Ceftriaxone, Dosage/Concentration: 1 G, Pharmaceutical Form: Powder For Injectable Solution (Br0442701), Celecoxib, Dosage/Concentration: 200 Mg (Br0268866), Ketoprofen, Pharmaceutical Form: Pharmaceutical Powder P/Injectable (Br0448844), Cyproterone Acetate, Dosage/Concentration: 2Mg + 0, 035Mg, Associated With Ethinilelestradiol (Br0271089), Clarithromycin, Dosage/Concentration: 500 Mg, Presentation: Injectable (Br0268440), Presentation: Slow Release (Br0269985), Clonidine) Hydrochloride, Dosage/Concentration: 0, 1 Mg (Br0272043), 15 Mg (Br0272044), 15 Mg/Ml, Pharmaceutical Form: Injectable Solution Ampoule 2Ml (Br0340206), Clopidogrel, Dosage/Concentration: 75 Mg, Chlorhexidine Diglucanato, Dosage: 2%, Application: Application: Application: Degermante 100Ml Bottle, Application: Degerman, 1Liter Bottle (Br0269876), Colchicine, 5 Mg (Br0267642), Colecalciferol, Dosage/Concentration: 3,300 Ui/Ml, Pharmaceutical Form: Oral Solution-Got Vasch 30Ml (Br0391938), Dishonestrel, Dosage/Concentration: 75 Mcg (Br0356701), Devenlafaxine, Succinate Salt, Controlled Release (Br0405898), Dexamethasone, Dosage/Concentration: 4 Mg/Ml, Pharmaceutical Form: Injectable Solution With 2, 5Ml, Dexclorphenide Maleate, 4 Mg/Ml, Presentation: Oral Solution 120Ml (Br0267646), Dosage/Concentration: 2 Mg (Br0267645), Diclofenac, Use: Injectable Solution, Dosage/Concentration: 25Mg
Key Value
Tender Value
1,751,090 - BRL
Tender Documents
Global Tender Document
c72c67cd-5044-49ee-b4e0-1ec3772369ff.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.